The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis

Gynecologic Oncology

Volumn 105, Issue 3, 2007, Pages 571-577

  Wang, Wei ^a   Wang, Shixuan ^a   Song, Xingfu ^b   Sima, Ni ^a   Xu, Xinhua ^b   Luo, Aiyue ^a   Chen, Gang ^a   Deng, Dongrei ^a   Xu, Qian ^a   Meng, Li ^a   Lu, Yunping ^a   Ma, Ding ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Yichang Central People's Hospital   (China)

Author keywords

Cellular FLICE like inhibitory protein; Cervical carcinogenesis; E2 gene; Human papillomavirus

Indexed keywords

FLICE INHIBITORY PROTEIN;

ARTICLE; CANCER RISK; CARCINOGENESIS; CONDYLOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; E2 GENE; FEMALE; GENE AMPLIFICATION; GENE DISRUPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS GENE; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 34248349532     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.01.051     Document Type: Article

References (34)

1. Werness B.A., Levine A.J., and Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990) 76-79
2. Dyson N., Howley P.M., Munger K., and Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 (1989) 934-937
3. Dowhanick J.J., McBride A.A., and Howley P.M. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69 (1995) 7791-7799
4. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 (1985) 111-114
5. Graham D.A., and Herrington C.S. HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities. Mol. Pathol. 53 (2000) 201-206
6. Maitland N.J., Conway S., Wilkinson N.S., Ramsdale J., Morris J.R., Sanders C.M., et al. Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia. J. Pathol. 186 (1998) 275-280
7. Stevenson M., Hudson L.C., Burns J.E., Stewart R.L., Wells M., and Maitland N.J. Inverse relationship between the expression of the human papillomavirus type 16 transcription factor E2 and virus DNA copy number during the progression of cervical intraepithelial neoplasia. J. Gen. Virol. 81 (2000) 1825-1832
8. Kalantari M., Karlsen F., Kristensen G., Holm R., Hagmar B., and Johansson B. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int. J. Gynecol. Pathol. 17 (1998) 146-153
9. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 (2002) 342-350
10. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
11. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., et al. Inhibition of death receptor signals by cellular FLIP. Nature 388 (1997) 190-195
12. Panka D.J., Mano T., Suhara T., Walsh K., and Mier J.W. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J. Biol. Chem. 276 (2001) 6893-6896
13. Muris J.J., Cillessen S.A., Vos W., van Houdt I.S., Kummer J.A., van Krieken J.H., et al. Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. Blood 105 (2005) 2916-2923
14. Ganten T.M., Haas T.L., Sykora J., Stahl H., Sprick M.R., Fas S.C., et al. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ. 11 Suppl. 1 (2004) S86-S96
15. Chawla-Sarkar M., Bae S.I., Reu F.J., Jacobs B.S., Lindner D.J., and Borden E.C. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 11 (2004) 915-923
16. Castle P.E., Wheeler C.M., Solomon D., Schiffman M., and Peyton C.L. Interlaboratory reliability of Hybrid Capture 2. Am. J. Clin. Pathol. 122 (2004) 238-245
17. Wu S., Xu Q., and Cheng G. The comparative study on HPV DNA test for cervical scraping smears with PCR mediated by two different primers. Tumor 24 (2004) 410-412
18. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., and Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61 (1987) 962-971
19. Meissner J.D. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 80 Pt. 7 (1999) 1725-1733
20. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur. J. Cancer 38 (2002) 2229-2242
21. Thomas R.K., Kallenborn A., Wickenhauser C., Schultze J.L., Draube A., Vockerodt M., et al. Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells. Am. J. Pathol. 160 (2002) 1521-1528
22. Mathas S., Lietz A., Anagnostopoulos I., Hummel F., Wiesner B., Janz M., et al. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis. J. Exp. Med. 199 (2004) 1041-1052
23. Griffith T.S., Chin W.A., Jackson G.C., Lynch D.H., and Kubin M.Z. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol. 161 (1998) 2833-2840
24. Djerbi M., Screpanti V., Catrina A.I., Bogen B., Biberfeld P., and Grandien A. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 190 (1999) 1025-1032
25. Medema J.P., de Jong J., van Hall T., Melief C.J., and Offringa R. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J. Exp. Med. 190 (1999) 1033-1038
26. Branca M., Ciotti M., Santini D., Di Bonito L., Giorgi C., Benedetto A., et al. p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int. J. Gynecol. Pathol. 23 (2004) 354-365
27. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85 (1993) 958-964
28. Corden S.A., Sant-Cassia L.J., Easton A.J., and Morris A.G. The integration of HPV-18 DNA in cervical carcinoma. Mol. Pathol. 52 (1999) 275-282
29. Peitsaro P., Johansson B., and Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 40 (2002) 886-891
30. Hopman A.H., Smedts F., Dignef W., Ummelen M., Sonke G., Mravunac M., et al. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J. Pathol. 202 (2004) 23-33
31. Durst M., Gallahan D., Jay G., and Rhim J.S. Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 173 (1989) 767-771
32. Webster K., Parish J., Pandya M., Stern P.L., Clarke A.R., and Gaston K. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J. Biol. Chem. 275 (2000) 87-94
33. Demeret C., Garcia-Carranca A., and Thierry F. Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein. Oncogene 22 (2003) 168-175
34. Scaffidi C., Schmitz I., Krammer P.H., and Peter M.E. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274 (1999) 1541-1548